Top

Published in:

01-03-2013 | Reviews

Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes

Authors: Andrea L. Pusic, Yeliz Cemal, Claudia Albornoz, Anne Klassen, Stefan Cano, Isabel Sulimanoff, Marisol Hernandez, Marga Massey, Peter Cordeiro, Monica Morrow, Babak Mehrara

Published in: Journal of Cancer Survivorship | Issue 1/2013

Abstract

Purpose

Lymphedema following breast cancer surgery remains a common and feared treatment complication. Accurate information on health-related quality of life (HRQOL) outcomes among patients with lymphedema is critically needed to inform shared medical decision making and evidence-based practice in oncologic breast surgery. Our systematic review aimed to (1) identify studies describing HRQOL outcomes in breast cancer-related lymphedema (BCRL) patients, (2) assess the quality of these studies, and (3) assess the quality and appropriateness of the patient-reported outcome (PRO) instruments used.

Methods

Using the PRISMA statement, we performed a systematic review including studies describing HRQOL outcomes among BCRL patients. Studies were classified by levels of evidence and fulfillment of the Efficace criteria. PRO instruments were assessed using the COSMIN criteria.

Results

Thirty-nine studies met inclusion criteria, including 8 level I and 14 level II studies. Sixteen of 39 studies were compliant with the Efficace criteria. Seventeen HRQOL instruments were used, two specific to lymphedema patients. Exercise and complex decongestive therapy treatment interventions were associated with improved HRQOL.

Conclusions

High-quality data on HRQOL outcomes is required to inform surgical decisions for breast cancer management and survivors. Of the lymphedema-specific PRO instruments, the Upper Limb Lymphedema 27 (ULL-27) was found to have strong psychometric properties. Future studies should strive to use high-quality condition- specific PRO instruments, follow existing guidelines for HRQOL measurement and to consider economic burdens of BCRL.

Implications for Cancer Survivors

As lymphedema may develop many years after breast cancer surgery, the ULL-27 may offer greater content validity for use in survivorship research.

Cancer Facts & Figures 2011. American Cancer Society. Atlanta, 2011.

Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J Clin Oncol. 2008;26(35):5689–96.PubMedCrossRef

Rockson SG. Lymphedema. Am J Med. 2001;110(4):288–95.PubMedCrossRef

Hormes JM, Bryan C, Lytle LA, et al. Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology. 2010;43(1):1–13.PubMed

Winters ZE, Benson JR, Pusic AL. A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient- reported outcome measures and health-related quality of life. Ann Surg. 2010;252(6):929–42.PubMedCrossRef

Pusic A, Liu JC, Chen CM, et al. A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngol Head Neck Surg. 2007;136(4):525–35.PubMedCrossRef

Efficace F, Bottomley A, Osoba D, et al. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials—does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol. 2003;21(18):3502–11.PubMedCrossRef

Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34.PubMedCrossRef

Making health care safer: a critical analysis of patient safety practices. Evidence-based review methodology (Chap. 3). http://www.ahrq.gov/clinic/ptsafety/chap3.htm. Accessed 23 Oct 2012.

10.

Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539–49.PubMedCrossRef

11.

Speck RM, Gross CR, Hormes JM, et al. Changes in the Body Image and Relationship Scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema. Breast Cancer Res Treat. 2010;2:421–30.CrossRef

12.

Kim do S, Sim YJ, Jeong HJ, Kim GC. Effect of active resistive exercise on breast cancer-related lymphedema: a randomized controlled trial. Arch Phys Med Rehabil. 2010;91(12):1844–8.PubMedCrossRef

13.

Tidhar D, Katz-Leurer M. Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: a randomized controlled study. Supportive Care in Cancer. 2010;18(3):383–92.PubMedCrossRef

14.

McClure MK, McClure RJ, Day R, Brufsky AM. Randomized controlled trial of the breast cancer recovery program for women with breast cancer-related lymphedema. Am J Occup Ther. 2010;64(1):59–72.PubMedCrossRef

15.

Tsai HJ, Hung HC, Yang JL, Huang CS, Tsauo JY. Could Kinesio tape replace the bandage in decongestive lymphatic therapy for breast-cancer-related lymphedema? A pilot study. Support Care Cancer. 2009;11:1353–60.CrossRef

16.

McKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol. 2003;21(3):463–6.PubMedCrossRef

17.

Williams AF, Vadgama A, Franks PJ, Mortimer PS. A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. Eur J Cancer Care (Engl). 2002;11(4):254–61.CrossRef

18.

Vassard D, Olsen MH, Zinckernagel L, Vibe-Petersen J, Dalton SO, Johansen C. Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort study. Eur J Cancer. 2010;46(18):3211–8.PubMedCrossRef

19.

Sagen A, Karesen R, Sandvik L, Risberg M. Changes in arm morbidities and health-related quality of life after breast cancer surgery: a five-year follow-up study. J Clin Oncol. 2009;27(15):e20602.

20.

Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2007;16(4):775–82.PubMedCrossRef

21.

Kim SJ, Yi CH, Kwon OY. Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral leymphedema. Lymphology. 2007;40(3):143–51.PubMed

22.

Cheema BS, Gaul CA. Full-body exercise training improves fitness and quality of life in survivors of breast cancer. J Strength Cond Res. 2006;20(1):14–21.PubMedCrossRef

23.

O’Neill J, Beatus J. The effects of complete decongestive physical therapy treatment on edema reduction, quality of life, and functional ability of persons with upper extremity lymphedema. J Women’s Health Phys Therapy. 2006;30(1):5–10.CrossRef

24.

Brorson H, Ohlin K, Olsson G, Langstrom G, Wiklund I, Svensson H. Quality of life following liposuction and conservative treatment of arm lymphedema. Lymphology. 2006;39(1):8–25.PubMed

25.

Wilburn O, Wilburn P, Rockson SG. A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. BMC Cancer. 2006;6:84.PubMedCrossRef

26.

Strauss-Blasche G, Gnad E, Ekmekcioglu C, Hladschik B, Marktl W. Combined inpatient rehabilitation and spa therapy for breast cancer patients: effects on quality of life and CA 15–3. Cancer Nurs. 2005;28(5):390–8.PubMedCrossRef

27.

Mondry TE, Riffenburgh RH, Johnstone PA. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy. Cancer J. 2004;10(1):42–8.PubMedCrossRef

28.

Turner J, Hayes S, Reul-Hirche H. Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. J Surg Oncol. 2004;86(3):141–6.PubMedCrossRef

29.

Coster S, Poole K, Fallowfield LJ. The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res Treat. 2001;68(3):273–82.PubMedCrossRef

30.

Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177(3):184–7.PubMedCrossRef

31.

Mirolo BR, Bunce IH, Chapman M, et al. Psychosocial benefits of postmastectomy lymphedema therapy. Cancer Nurs. 1995;18(3):197–205.PubMedCrossRef

32.

Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg. 2002;137(11):1253–7.PubMedCrossRef

33.

Nesvold IL, Foss SD, Holm I, Naume B, Dahl AA. Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol. 2010;49(3):347–53.PubMedCrossRef

34.

Nesvold IL, Reinertsen KV, Fossa SD, Dahl AA. The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study. J Cancer Surviv. 2010;5(1):62–72.PubMedCrossRef

35.

Chachaj A, Malyszczak K, Pyszel K, et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology. 2010;19(3):299–305.PubMedCrossRef

36.

Mak SS, Mo KF, Suen JJ, Chan SL, Ma WL, Yeo W. Lymphedema and quality of life in Chinese women after treatment for breast cancer. Eur J Oncol Nurs. 2009;13(2):110–5.PubMedCrossRef

37.

Paim CR, de Paula Lima ED, Fu MR, de Paula Lima A, Cassali GD. Post lymphadenectomy complications and quality of life among breast cancer patients in Brazil. Cancer Nurs. 2008;31(4):302–9.PubMedCrossRef

38.

Pyszel A, Malyszczak K, Pyszel K, Andrzejak R, Szuba A. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology. 2006;39(4):185–92.PubMed

39.

Ridner SH, Dietrich MS, Kidd N. Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life. Support Care Cancer. 2011;19(5):631–7.PubMedCrossRef

40.

Karadibak D, Yavuzsen T, Saydam S. Prospective trial of intensive decongestive physiotherapy for upper extremity lymphedema. J Surg Oncol. 2008;97(7):572–7.PubMedCrossRef

41.

Dawes DJ, Meterissian S, Goldberg M, Mayo NE. Impact of lymphoedema on arm function and health-related quality of life in women following breast cancer surgery. J Rehabil Med. 2008;40(8):651–8.PubMedCrossRef

42.

Heiney SP, McWayne J, Cunningham JE, et al. Quality of life and lymphedema following breast cancer. Lymphology. 2007;40(4):177–84.PubMed

43.

Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer. 2005;13(11):904–11.PubMedCrossRef

44.

Wilson RW, Hutson LM, Vanstry D. Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: the RAND 36-Item Health Survey and the Functional Living Index-Cancer. Phys Ther. 2005;85(9):851–60.PubMed

45.

Pain SJ, Vowler SL, Purushotham AD. Is physical function a more appropriate measure than volume excess in the assessment of breast cancer-related lymphoedema (BCRL)? Eur J Cancer. 2003;39(15):2168–72.PubMedCrossRef

46.

Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20(20):4242–8.PubMedCrossRef

47.

Kirshbaum M. The development, implementation and evaluation of guidelines for the management of breast cancer related lymphoedema. Eur J Cancer Care (Engl). 1996;5(4):246–51.CrossRef

48.

Launois R, Megnigbeto AC, Pocquet K, Alliot F. A specific quality of life scale in upper limb lymphoedema: the ULL-27 questionnaire. Lymphology. 2002;35(1–760):181–7.

49.

Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol. 1984;2(5):472–83.PubMed

50.

Cemal Y, Pusic A, Mehrara BJ. Preventative measures for lymphedema: separating fact from fiction. J Am Coll Surg. 2011;213(4):543–51.PubMedCrossRef

Title: Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes
Authors: Andrea L. Pusic
Yeliz Cemal
Claudia Albornoz
Anne Klassen
Stefan Cano
Isabel Sulimanoff
Marisol Hernandez
Marga Massey
Peter Cordeiro
Monica Morrow
Babak Mehrara
Publication date: 01-03-2013
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 1/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-012-0247-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 1/2013

Are cancer registries a viable tool for cancer survivor outreach? A feasibility study

Physical activity and/or dietary interventions in breast cancer survivors: a systematic review of the maintenance of outcomes

Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study

Evaluation of the efficacy and usability of NCI’s Facing Forward booklet in the cancer community setting

The experience of information sharing among primary care clinicians with cancer survivors and their oncologists

Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia

Keynote webinar | Spotlight on antibody–drug conjugates in cancer